Huayining® Glipizide Tablets
Specification: 5mg

National Medical Insurance Class A

Huayining® Glipizide  Tablets is a second-generation sulfonylurea oral hypoglycemic drug. It can promote the secretion of insulin by pancreatic islet β cells and enhance the effect of insulin on target tissues; It can also stimulate pancreatic islet A cells to inhibit glucagon secretion, inhibit liver glycogen decomposition, promote muscle utilization and glucose consumption.


Primary Indications

For type II diabetes


The Main Contraindication To Medication

1. Type I diabetes, diabetic ketosis, diabetic precoma or coma phase.

2. Liver insufficiency, adrenal insufficiency and allergies to this product are prohibited.


Dosage Form

Tablets

Online Consultation
Huayining® Glipizide  Tablets
More Products